GOSS — GOSSAMER BIO INC

Ownership history in Callan Capital, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which Callan Capital, LLC reported a position in GOSSAMER BIO INC (GOSS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q1 ADDED 30,000 +10,000 +50.0% 0.00% $32K $1.10
2024 Q4 REDUCED 20,000 -10,000 -33.3% 0.00% $13K $0.90
2024 Q4 INITIATED 30,000 — — 0.00% $27K $0.90
% of Fund (quarterly)    GOSS price (monthly, adj. close)

Other funds also holding GOSS

As of 2025 Q4 — sorted by position size

Octagon Capital Advisors LP 3Y 5.24% ARCH Venture Management, LLC 3Y 7Y 3.83% NEA Management Company, LLC 3Y 7Y 2.86% MB Generational Wealth, LLC 2.63% Samsara BioCapital, LLC 3Y 7Y 2.31% Palo Alto Investors LP 3Y 7Y 1.93% Monashee Investment Management LLC 3Y 7Y 1.75% Opaleye Management Inc. 3Y 7Y 1.11% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 0.92% 683 Capital Management, LLC 3Y 7Y 0.7%
← Back to Callan Capital, LLC Holdings